How tissue engineering costs and competition will be hit by EU proposals
This article was originally published in Clinica
Executive Summary
The level of additional costs that tissue engineering companies will face with the implementation of the European Commission's proposed Advanced Therapies Regulation, as well as their ability to cope with these costs and compete, will depend mainly of the applicant's profile, the Commission says.